Status:
UNKNOWN
Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Warts
Eligibility:
All Genders
10-80 years
Brief Summary
Photodynamic therapy (PDT) has been developed as a promising new cancer treatment modality, which involves the uptakes of a photosensitizer by tumor cells, followed by the activation of photosensitize...
Detailed Description
Verruca vulgaris or warts are benign skin papillomas caused by the human papilloma virus (HPV). They are very common and can affect many different sites including the face, hands, feet and genitalia. ...
Eligibility Criteria
Inclusion
- Warts -
Exclusion
- other skin lesions or combined with infection -
Key Trial Info
Start Date :
December 1 1994
Trial Type :
OBSERVATIONAL
End Date :
December 1 1996
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00155584
Start Date
December 1 1994
End Date
December 1 1996
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan